Quince Therapeutics, Inc.https://investorshangout.com/Quince-Therapeutics-Inc-QNCX-53795/en-usFri, 04 Sep 2026 01:29:33 GMTCopyright InvestorsHangout.comznewcar1: $QNCX 33% v63,8M c1.08 f36,130M H1.47 ML.54 H1.47https://investorshangout.com/post/view?id=6528570https://investorshangout.com/post/view?id=6528570Fri, 27 Jan 2023 21:33:38 GMTznewcar1: QNCX was CRTXhttps://investorshangout.com/post/view?id=6456828https://investorshangout.com/post/view?id=6456828Thu, 18 Aug 2022 03:23:13 GMTwhytestocks: $CRTX News Article - Cortexyme Announces Agreement to Acquire Novosteo https://investorshangout.com/post/view?id=6399859https://investorshangout.com/post/view?id=6399859Tue, 10 May 2022 14:45:51 GMTwhytestocks: $CRTX News Article - Cortexyme Provides New GAIN Trial Data at AD/PD 2022 Demonstrating Potential Behttps://investorshangout.com/post/view?id=6366859https://investorshangout.com/post/view?id=6366859Mon, 21 Mar 2022 12:56:18 GMTwhytestocks: $CRTX News Article - Cortexyme to Present New GAIN Trial Data at AD/PD 2022 https://investorshangout.com/post/view?id=6362108https://investorshangout.com/post/view?id=6362108Mon, 14 Mar 2022 16:06:24 GMTwhytestocks: $CRTX News Article - Cortexyme Announces Preclinical Data Highlighting Potential Therapeutic Benefithttps://investorshangout.com/post/view?id=6358799https://investorshangout.com/post/view?id=6358799Wed, 09 Mar 2022 13:50:56 GMTwhytestocks: $CRTX News Article - Cortexyme Reports Safety and Pharmacokinetics Results from Single Ascending Doshttps://investorshangout.com/post/view?id=6358105https://investorshangout.com/post/view?id=6358105Tue, 08 Mar 2022 16:10:51 GMTwhytestocks: $CRTX News Article - Cortexyme to Present at Canaccord Genuity' s 41st Annual Growth Conference on Ahttps://investorshangout.com/post/view?id=6205805https://investorshangout.com/post/view?id=6205805Wed, 04 Aug 2021 15:30:49 GMTwhytestocks: $CRTX News Article - Cortexyme Announces Lead 3CLpro Inhibitor for the Treatment of Coronavirus Infehttps://investorshangout.com/post/view?id=6194299https://investorshangout.com/post/view?id=6194299Fri, 23 Jul 2021 12:15:48 GMTwhytestocks: $CRTX News Article - Cortexyme to Host Symposium at AAIC 2021 https://investorshangout.com/post/view?id=6189536https://investorshangout.com/post/view?id=6189536Mon, 19 Jul 2021 17:40:48 GMTAviseAnalytics: CRTX 5 MOST PROMISING ALZHEIMER’S DISEASE STOCK! Insert-tag-here httphttps://investorshangout.com/post/view?id=6165144https://investorshangout.com/post/view?id=6165144Tue, 22 Jun 2021 11:58:51 GMTwhytestocks: $CRTX News Article - Cortexyme to Present at Investor Conferences in June 2021 https://investorshangout.com/post/view?id=6145751https://investorshangout.com/post/view?id=6145751Wed, 26 May 2021 16:35:51 GMTwhytestocks: $CRTX News Article - Cortexyme Announces Leadership Appointments to Support Advancement of Atuzaginshttps://investorshangout.com/post/view?id=6049633https://investorshangout.com/post/view?id=6049633Wed, 10 Feb 2021 21:10:50 GMTwhytestocks: $CRTX News Article - Cortexyme Presents an Update and Baseline Data from the Phase 2/3 GAIN Trial ofhttps://investorshangout.com/post/view?id=5952867https://investorshangout.com/post/view?id=5952867Thu, 05 Nov 2020 16:40:55 GMTwhytestocks: $CRTX News Article - Cortexyme Announces Upcoming Data Presentations at November 2020 Conferences https://investorshangout.com/post/view?id=5934117https://investorshangout.com/post/view?id=5934117Mon, 19 Oct 2020 12:35:46 GMTwhytestocks: $CRTX News Article - Cortexyme Announces Issuance of Composition of Matter Patent for Atuzaginstat bhttps://investorshangout.com/post/view?id=5876341https://investorshangout.com/post/view?id=5876341Thu, 27 Aug 2020 19:10:47 GMTwhytestocks: $CRTX News Article - Cortexyme Announces "Atuzaginstat" Selected as First-in-Class Nonproprietary Nahttps://investorshangout.com/post/view?id=5790919https://investorshangout.com/post/view?id=5790919Tue, 09 Jun 2020 14:35:41 GMTwhytestocks: $CRTX News Article - Cortexyme Provides Regulatory Update for COR388 Development Program in Alzheimehttps://investorshangout.com/post/view?id=5674062https://investorshangout.com/post/view?id=5674062Thu, 13 Feb 2020 13:15:41 GMTwhytestocks: $CRTX News Article - Cortexyme Announces Closing of $125 Million Private Placement https://investorshangout.com/post/view?id=5671124https://investorshangout.com/post/view?id=5671124Mon, 10 Feb 2020 21:10:40 GMTwhytestocks: $CRTX News Article - Cortexyme Announces the Initiation of an Open-Label Extension Study for the GAIhttps://investorshangout.com/post/view?id=5641657https://investorshangout.com/post/view?id=5641657Mon, 13 Jan 2020 16:45:43 GMTznewcar1: CRTX 39% v1.3M c66.08 f26M H 68 shot up from 47 to 58 looking strong after hours.https://investorshangout.com/post/view?id=5625069https://investorshangout.com/post/view?id=5625069Fri, 20 Dec 2019 22:00:44 GMTwhytestocks: $CRTX News Article - Cortexyme's Approach to Addressing a Key Underlying Cause of Alzheimer's Detailhttps://investorshangout.com/post/view?id=5485585https://investorshangout.com/post/view?id=5485585Wed, 17 Jul 2019 16:00:40 GMTwhytestocks: $CRTX News Article - Cortexyme Announces Upcoming Data Presentations at the Alzheimer's Association https://investorshangout.com/post/view?id=5479964https://investorshangout.com/post/view?id=5479964Wed, 10 Jul 2019 12:15:39 GMTStock_Tracker: Latest Cornerstone Therapeutics Inc (CRTX) Headlines Healthfirst Improves Member Retention Using https://investorshangout.com/post/view?id=1327366https://investorshangout.com/post/view?id=1327366Thu, 13 Mar 2014 11:10:05 GMT